CHARLES SCHWAB INVESTMENT MANAGEMENT INC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 3 filers reported holding REGENXBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$5,362,141
-10.0%
325,768
+9.3%
0.00%0.0%
Q2 2023$5,960,578
+8.8%
298,178
+3.0%
0.00%0.0%
Q1 2023$5,476,469
-16.0%
289,607
+0.7%
0.00%0.0%
Q4 2022$6,522,020
-11.5%
287,567
+3.1%
0.00%
-33.3%
Q3 2022$7,370,000
+8.7%
278,828
+1.6%
0.00%
+50.0%
Q2 2022$6,778,000
-28.9%
274,397
-4.5%
0.00%
-33.3%
Q1 2022$9,535,000
+1.2%
287,286
-0.3%
0.00%0.0%
Q4 2021$9,426,000
-21.0%
288,238
+1.2%
0.00%
-25.0%
Q3 2021$11,935,000
+15.8%
284,700
+7.3%
0.00%
+33.3%
Q2 2021$10,305,000
+22.9%
265,229
+7.9%
0.00%0.0%
Q1 2021$8,385,000
-10.5%
245,822
+19.0%
0.00%
-25.0%
Q4 2020$9,367,000
+66.9%
206,494
+1.3%
0.00%
+33.3%
Q3 2020$5,611,000
-29.4%
203,869
-5.5%
0.00%
-25.0%
Q2 2020$7,949,000
+21.0%
215,817
+6.3%
0.00%0.0%
Q1 2020$6,572,000
-18.7%
202,960
+2.9%
0.00%0.0%
Q4 2019$8,079,000
+17.8%
197,176
+2.3%
0.00%0.0%
Q3 2019$6,860,000
-28.1%
192,693
+3.7%
0.00%
-33.3%
Q2 2019$9,546,000
-20.4%
185,824
-11.2%
0.01%
-25.0%
Q1 2019$11,990,000
+48.1%
209,208
+8.4%
0.01%
+33.3%
Q4 2018$8,097,000
-42.5%
193,009
+3.5%
0.01%
-33.3%
Q3 2018$14,082,000
+36.1%
186,515
+29.3%
0.01%
+12.5%
Q2 2018$10,347,000
+156.6%
144,208
+6.7%
0.01%
+166.7%
Q1 2018$4,033,000
-5.4%
135,094
+5.4%
0.00%0.0%
Q4 2017$4,263,000
+5.6%
128,187
+4.6%
0.00%
-25.0%
Q3 2017$4,037,000
+109.2%
122,509
+25.4%
0.00%
+100.0%
Q2 2017$1,930,000
+35.6%
97,695
+32.5%
0.00%
+100.0%
Q1 2017$1,423,000
+10.4%
73,724
+6.2%
0.00%0.0%
Q4 2016$1,289,000
+40.1%
69,449
+5.9%
0.00%0.0%
Q3 2016$920,000
+181.3%
65,599
+60.9%
0.00%
Q2 2016$327,000
+31.3%
40,778
+77.4%
0.00%
Q1 2016$249,000
-33.8%
22,984
+1.6%
0.00%
-100.0%
Q4 2015$376,00022,6270.00%
Other shareholders
REGENXBIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 1,459,128$110,164,0006.60%
ArchPoint Investors 224,187$16,926,0004.60%
Redmile Group, LLC 1,656,065$125,033,0003.85%
WS MANAGEMENT LLLP 954,812$72,088,0002.37%
HIGHLINE CAPITAL MANAGEMENT, L.P. 342,000$25,821,0001.19%
Perceptive Advisors 470,672$35,536,0000.95%
Pier Capital, LLC 94,492$7,134,0000.90%
Ipswich Investment Management Co., Inc. 29,932$2,260,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,000$20,763,0000.74%
Timpani Capital Management LLC 27,835$2,102,0000.61%
View complete list of REGENXBIO INC shareholders